University of Dundee

Latest News for 05/2022

September 2019

  • Dr Peter van den Akker and Dr Aileen Sandilands
    24 Sep 2019

    DEBRA is delighted to share that funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa (EB) has been agreed. £153,550 towards a total of £504,472 has been provided to enable the team lead by DEBRA Clinical Fellow, Dr Peter van den Akker (pictured), to develop two types of gene technology that can target genetic mutations caused by EB.